Literature DB >> 12725359

Acinetobacter outbreaks, 1977-2000.

Maria Virginia Villegas1, Alan I Hartstein.   

Abstract

This review of Acinetobacter outbreaks summarizes factors related to the presence and recognition of organism transmission and describes the implementation of control and prevention measures directed at limiting spread. Exogenous transmission of Acinetobacter should be considered when infections are endemic and when case rates increase. Increasing or new antimicrobial resistances in a collection of isolates also suggest transmission, and transmission can be definitively confirmed when isolates are found to be indistinguishable from or related to one another by a discriminatory genotyping test. An investigation for a common source should be conducted. When a common source cannot be found and eliminated, or once an endemically transmitted organism is established, containment or prevention efforts may require aggressive interventions, complex interventions, or both. Colonization at multiple sites, the relative ease of induction of antibiotic resistance in the organism following patient exposure to multiple drugs, and long-term environmental survival provide enhanced opportunities for the transmission of Acinetobacter between and among patients. New approaches and interventional trials are needed to define effective measures for the prevention and control of Acinobacter infections.

Entities:  

Mesh:

Year:  2003        PMID: 12725359     DOI: 10.1086/502205

Source DB:  PubMed          Journal:  Infect Control Hosp Epidemiol        ISSN: 0899-823X            Impact factor:   3.254


  127 in total

1.  Genomewide analysis of divergence of antibiotic resistance determinants in closely related isolates of Acinetobacter baumannii.

Authors:  Mark D Adams; E Ricky Chan; Neil D Molyneaux; Robert A Bonomo
Journal:  Antimicrob Agents Chemother       Date:  2010-06-07       Impact factor: 5.191

2.  Clonal diversity of nosocomial epidemic Acinetobacter baumannii strains isolated in Spain.

Authors:  Pilar Villalón; Sylvia Valdezate; Maria J Medina-Pascual; Virginia Rubio; Ana Vindel; Juan A Saez-Nieto
Journal:  J Clin Microbiol       Date:  2010-12-22       Impact factor: 5.948

3.  Longitudinal epidemiology of multidrug-resistant (MDR) Acinetobacter species in a tertiary care hospital.

Authors:  Ji Hoon Baang; Peter Axelrod; Brooke K Decker; Andrea M Hujer; Georgia Dash; Allan R Truant; Robert A Bonomo; Thomas Fekete
Journal:  Am J Infect Control       Date:  2011-08-11       Impact factor: 2.918

4.  The K1 capsular polysaccharide of Acinetobacter baumannii strain 307-0294 is a major virulence factor.

Authors:  Thomas A Russo; Nicole R Luke; Janet M Beanan; Ruth Olson; Shauna L Sauberan; Ulrike MacDonald; L Wayne Schultz; Timothy C Umland; Anthony A Campagnari
Journal:  Infect Immun       Date:  2010-07-19       Impact factor: 3.441

5.  Investigation of the molecular epidemiology of Acinetobacter baumannii isolated from patients and environmental contamination.

Authors:  Chunmei Ying; Yongli Li; Yaping Wang; Bing Zheng; Chengde Yang
Journal:  J Antibiot (Tokyo)       Date:  2015-04-15       Impact factor: 2.649

6.  In-silico modeling of a novel OXA-51 from β-lactam-resistant Acinetobacter baumannii and its interaction with various antibiotics.

Authors:  Vishvanath Tiwari; Isha Nagpal; Naidu Subbarao; Rajeswari R Moganty
Journal:  J Mol Model       Date:  2012-01-22       Impact factor: 1.810

7.  Multicity outbreak of carbapenem-resistant Acinetobacter baumannii isolates producing the carbapenemase OXA-40.

Authors:  Karen Lolans; Thomas W Rice; L Silvia Munoz-Price; John P Quinn
Journal:  Antimicrob Agents Chemother       Date:  2006-09       Impact factor: 5.191

8.  Interaction of Acinetobacter baumannii 19606 and 1656-2 with Acanthamoeba castellanii.

Authors:  Migma Dorji Tamang; Shukho Kim; Sung-Min Kim; Hyun-Hee Kong; Jungmin Kim
Journal:  J Microbiol       Date:  2011-11-09       Impact factor: 3.422

9.  OXA-58 and IMP-4 carbapenem-hydrolyzing beta-lactamases in an Acinetobacter junii blood culture isolate from Australia.

Authors:  Anton Y Peleg; Clare Franklin; Luke J Walters; Jan M Bell; Denis W Spelman
Journal:  Antimicrob Agents Chemother       Date:  2006-01       Impact factor: 5.191

10.  Multidrug-resistant Acinetobacter baumannii in New York City - 10 years into the epidemic.

Authors:  Daniel J Morgan; Scott A Weisenberg; Michael H Augenbraun; David P Calfee; Brian P Currie; E Yoko Furuya; Robert Holzman; Marisa C Montecalvo; Michael Phillips; Bruce Polsky; Kent A Sepkowitz
Journal:  Infect Control Hosp Epidemiol       Date:  2009-02       Impact factor: 3.254

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.